Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks Rise As It's Third Time Unlucky For PM May

Fri, 29th Mar 2019 17:05

LONDON (Alliance News) - Stocks in London ended higher on Friday amid continued optimism over the ongoing trade talks between the US and China.In a post on Twitter this morning, Treasury Secretary Steven Mnuchin described the latest round of high-level US trade talks as "constructive."Mnuchin also said he looks forward to welcoming China's Vice Premier Liu He to continue the important discussions in Washington next week.Additionally, the FTSE 100 was lifted by weakness in the pound as MPs rejected UK Prime Minister Theresa May's Brexit deal for a third time.The FTSE 100 index closed up 44.86 points to finish 0.6% higher at 7,279.19, ending the week up 1.0%.The FTSE 250 ended 1.1%, or 208.90 points, at 19,117.49, ending the week up 0.6% and the AIM All-Share closed 0.6%, or 5.68 points, at 916.83, ending the week up 0.9%.The Cboe UK 100 ended up 0.7% at 12,359.33, the Cboe UK 250 closed up 0.9% at 17,126.05, while the Cboe Small Companies finished up 0.2% at 11,179.08. In Paris the CAC 40 ended 1.0% higher, while the DAX 30 in Frankfurt ended up 0.9%. "Optimism that the US and China were moving towards a trade agreement has boosted risk appetite. Whilst any agreement could still be some months in the making, Economic Advisor Larry Kudlow hinted that some tariffs on Chinese imports could be removed. Progress in the US-Sino trade dispute is ensuring a strong end to the quarter for equities, despite lingering concerns over the health of the global economy," said City Index analyst Fiona Cincotta. In the FTSE 100, miners ended in the green with Antofagasta, up 3.6%, Glencore, up 2.0%, Anglo American, up 3.1%, Rio Tinto, up 1.8% and BHP, up 1.7%. "Shanghai's SSE Composite index jumped 3.2% on hopes that the US and China were making progress with trade talks. This optimism also gave a boost to the London-listed natural resources sector with mining shares topping the list of FTSE 100 risers," noted AJ Bell's Russ Mould.At the other end of the large-cap index, AstraZeneca ended as the worst performer, down 5.6%, after the Anglo-Swedish drugmaker launched a USD3.5 billion equity issue as part of a deal to license half the rights to a cancer treatment from Japan's Daiichi Sankyo.The agreement relates to Daiichi Sankyo's drug trastuzumab deruxtecan and will see AstraZeneca pay USD1.35 billion upfront, with further payments linked to sales targets.Under the terms of the deal, the two companies will jointly develop and commercialise trastuzumab deruxtecan worldwide, except in Japan where Daiichi Sankyo will maintain exclusive rights."Astra clearly felt the pipeline needed another shot in the arm, hence the Daiichi Sankyo deal. It's a high risk bet. The drug in question hasn't been approved in any markets, so there's always the risk it falls at the final hurdle and ends up being worth nothing at all," Hargreaves Lansdown analyst Nicholas Hyett said. TUI ended down 4.4% after the Anglo-German travel company warned that the grounding of the Boeing 737 Max aircraft will hit annual earnings and will result in a large exceptional charge.Boeing 737 Max aircrafts have been grounded by countries around the world following two fatal crashes in the past five months. Assuming resumption of 737 Max flights by mid-July, TUI is estimating a one-off charge of EUR200 million on adjusted earnings before interest, taxes and amortisation for its financial year to the end of September. As a result of the exceptional charge, TUI expects underlying Ebitda for 2019 financial to fall by 17%, versus previous broadly flat guidance.If the plane is not flying by mid-July, the annual hit will be even larger, TUI warned.The pound was quoted at USD1.3024 at the London equities close, marginally lower than USD1.3044 at the close Thursday, after May lost the battle to get her Brexit Withdrawal Agreement backed by the Commons on the day the UK was scheduled to quit the EU.May said she will seek an "alternative way forward" after parliament rejected her Brexit deal for the third time. The House of Commons rejected the deal by 344 to 286 votes.Following the vote, May said the result was a matter of "profound regret," warning that it would have "grave" implications."The legal default now is that the UK is due to leave the EU on April 12," she said. There are concerns that a no-deal exit could cause severe disruptions to trade and create havoc at the borders."This is not enough time to agree, legislate for and ratify a deal, and yet the house has been clear it will not permit leaving without a deal," May said. "And so we will have to agree an alternative way forward".In Brussels, European Council President Donald Tusk said on Twitter that EU leaders will hold a special Brexit summit on April 10 following the latest rejection of the withdrawal agreement.A spokesman said the European Commission is now "fully prepared" for the UK to leave the bloc without a deal on April 12, unless it calls for a longer extension and participates in EU elections in late May."The switch of high profile Conservative MPs such as Boris Johnson and Jacob Rees Mogg raised hopes going into the vote, but without the DUP support this was always likely to prove a fruitless endeavour. Even if the 10 DUP MPs supported the government, the size of the margin still would represent a significant hurdle to overcome. In terms of procedure, the next event to watch is another round of indicative votes scheduled for Monday, but at the risk of sounding skeptical, hopes of a breakthrough their look wishful to say the least," said XTB analyst David Cheatham.The euro stood at USD1.1227 at the European equities close, flat compared to USD1.1223 late Thursday. In economic news from the continent, German unemployment continued its declining trend in March as the jobless rate fell to a record low.The seasonally adjusted jobless rate dropped to a German reunification-low of 4.9% from 5.0%, where it was since November. The easing was in line with economists' expectations.Stocks in New York were higher at the London equities close amid continued optimism over the ongoing trade talks between the US and China.The DJIA was up 0.3%, the S&P 500 index up 0.4% and the Nasdaq Composite up 0.5%.On the economic front, a report released by the Commerce Department showed personal income in the US increased by slightly less than anticipated in the month of February.The report said personal income rose by 0.2% in February after edging down by 0.1% in January. Economists had expected personal income to climb by 0.3%.Reflecting the continued impact of the recent government shutdown, the Commerce Department also released data on personal spending in January but not February.Last week, the US Federal Reserve abandoned projections for any interest rate hikes in 2019 - after raising rates four times in 2018 - amid concerns over a slowing economy, low inflation and rising headwinds to growth."Domestic demand is clearly now slowing and, with the fiscal boost having faded and higher interest rates taking a heavier toll, we expect that to continue," said Andrew Hunter, senior US economist at Capital Economics.Personal spending inched up by 0.1% in January after falling by 0.6% in December, while economists had expected spending to increase by 0.3%.The Personal Consumption Expenditures price index rose 1.4% on an annual basis in January which followed a 1.8% increase in December.Excluding volatile food and energy components, the PCE price index ticked up 0.1% in January after rising 0.2% in the prior month. The core PCE price index decreased to 1.8% in January from 2.0% in December - missing market expectations of 1.9%. The core PCE index is the Fed's preferred inflation measure. "Low inflation has been a key characteristic of the post-recession decade with inflation systematically undershooting the Fed's 2.0% target. While some still fear a sudden break-out, we believe that low inflation reflects weaker underlying growth dynamics, a more subdued wage-unemployment trade-off, globalisation, corporate concentration and increasingly low and anchored inflation expectations - all likely to remain in place in the long run," said analysts at Oxford Economics. Meanwhile, all eyes were on Lyft on Friday as the ride-hail company made its hotly anticipated stock market debut. Lyft listed on Nasdaq with its initial public offering price at USD72 a share. The IPO price was above the original target range of USD62 to USD68. The stock was trading at USD87.24 a share, up 21% from its IPO price, valuing the Silicon Valley company at around USD24.3 billion. The Uber-rival's IPO was the biggest since Jack Ma's Alibaba in 2014. It marks the start of what is set to be a stellar year in the IPO market in the US, with more "unicorns" - a privately held startup valued at over USD1 billion - set to trot onto public markets. Beloved social media platform Pinterest, room-booking service Airbnb and ride sharing firm Uber are all expected to join the rush of US tech IPOs in 2019. Brent oil was quoted at USD67.55 a barrel at the London equities close, up from USD67.45 at the close Thursday. Gold was quoted at USD1,295.00 an ounce at the London equities close, up from USD1,290.62 late Thursday.The economic events calendar on Monday has manufacturing PMI readings from China at 0245 BST, Italy at 0845 BST, France at 0750 BST, Germany at 0855 BST, eurozone at 0900 BST and UK at 0930 BST. There is also eurozone inflation figures at 0900 BST. The corporate calendar on Monday has a trading statement from engineering services firm Renew Holdings.

More News
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.